Abstract | PURPOSE:
Cancer diagnostics and therapeutics are often based on clinically relevant markers that are expressed specifically in a malignant tissue at levels higher than in normal tissue. We examined potential markers for papillary thyroid carcinoma (PTC) by monitoring PTC-specific gene expression using cDNA microarray. EXPERIMENTAL DESIGN: Gene expression profiles for PTC tissue, normal thyroid tissue, and healthy peripheral blood cells were compared by use of a human 4000-gene cDNA microarray. Protein expressions of the up-regulated genes in PTC were examined in thyroid tissues by immunohistochemistry. RESULTS: CONCLUSIONS:
|
Authors | Yukiko Yano, Naoya Uematsu, Tohru Yashiro, Hisato Hara, Ei Ueno, Masanao Miwa, Gozoh Tsujimoto, Yuji Aiyoshi, Kazuhiko Uchida |
Journal | Clinical cancer research : an official journal of the American Association for Cancer Research
(Clin Cancer Res)
Vol. 10
Issue 6
Pg. 2035-43
(Mar 15 2004)
ISSN: 1078-0432 [Print] United States |
PMID | 15041723
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Genetic Markers
- Platelet-Derived Growth Factor
|
Topics |
- Carcinoma, Papillary
(genetics)
- Cell Cycle
(genetics, physiology)
- Gene Expression Profiling
(methods)
- Gene Expression Regulation
- Gene Expression Regulation, Neoplastic
- Genetic Markers
- Humans
- Oligonucleotide Array Sequence Analysis
(methods)
- Platelet-Derived Growth Factor
(genetics)
- Reference Values
- Thyroid Gland
(cytology, physiology)
- Thyroid Neoplasms
(genetics, pathology)
|